Skip to main content
Equibles

FMR LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 315066 BOSTON, MA
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$146,340,306
-$59,436,345 QoQ
Shares Held
10,043,947
-7.5% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 242 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. SMMT ranks #78 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in SMMT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,340,306 10,043,947
2026-03-31 $205,776,651 10,853,199
2025-12-31 $233,680,513 13,360,807
2025-09-30 $184,243,543 8,917,887
2025-06-30 $196,337,279 9,226,376
2025-03-31 $180,134,320 9,338,223
2024-12-31 $143,748,075 8,055,370
2024-09-30 $181,838,304 8,303,119
2024-06-30 $59,010,329 7,565,427
2024-03-31 $33,014,557 7,974,531
2023-12-31 $24,330 9,322
2023-09-30 $5,776 3,089
2023-06-30 $1,568 625
2022-03-31 $1,786 729